OCULAR THERAPEUTIX, INC (OCUL) Costs and Expenses USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Ocular Therapeutix, Inc quarterly/annual Costs and Expenses history and growth rate from 2015 to 2024.
  • Ocular Therapeutix, Inc Costs and Expenses for the quarter ending March 31, 2024 was $46.4 M, a 29.1% increase year-over-year.
  • Ocular Therapeutix, Inc Costs and Expenses for the twelve months ending March 31, 2024 was $151 M, a 12% increase year-over-year.
  • Ocular Therapeutix, Inc annual Costs and Expenses for 2023 was $141 M, a 8.2% increase from 2022.
  • Ocular Therapeutix, Inc annual Costs and Expenses for 2022 was $130 M, a 7.07% increase from 2021.
  • Ocular Therapeutix, Inc annual Costs and Expenses for 2021 was $122 M, a 51.5% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $151 M $46.4 M +$10.5 M +29.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $141 M $34.9 M +$1.41 M +4.23% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $139 M $34.3 M +$786 K +2.35% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $139 M $35.8 M +$3.57 M +11.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $135 M $35.9 M +$4.9 M +15.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $130 M $33.4 M +$3.08 M +10.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $127 M $33.5 M +$1.83 M +5.77% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $125 M $32.2 M +$233 K +0.73% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $125 M $31 M +$3.45 M +12.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $122 M $30.4 M +$8.67 M +40% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 $113 M $31.7 M +$11.8 M +59.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $101 M $31.9 M +$12.5 M +64.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $88.6 M $27.6 M +$8.35 M +43.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $80.3 M $21.7 M -$1.97 M -8.31% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $82.2 M $19.9 M -$4.09 M -17.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $86.3 M $19.5 M -$2.8 M -12.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $89.1 M $19.2 M -$927 K -4.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $90 M $23.7 M +$5.87 M +33% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $84.2 M $24 M +$8.66 M +56.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $75.5 M $22.2 M +$8.04 M +56.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $67.5 M $20.2 M +$6.36 M +46.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $61.1 M $17.8 M +$4.58 M +34.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $56.5 M $15.3 M -$405 K -2.58% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $56.9 M $14.2 M -$4.57 M -24.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $61.5 M $13.8 M -$2.35 M -14.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $63.8 M $13.2 M +$220 K +1.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $63.6 M $15.7 M +$6 M +61.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $57.6 M $18.8 M +$7.23 M +62.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $50.4 M $16.1 M +$5.18 M +47.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $45.2 M $13 M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $9.72 M -$1.89 M -16.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $11.5 M +$1.45 M +14.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $11 M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q3 2015 $11.6 M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $10.1 M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.